Aurora Spine Corp. · TSXV:ASG
Aurora Spine — Investor Presentation (2025)
28 slides from Aurora Spine's investor presentation, 2025
Slide 1: Investor Presentation Spring 2025
Investor Presentation TSXV: ASG Spring 2025 OTCQB: ASAPF Aurora Spine, Inc.
Slide 2: Forward Looking Disclaimer
Forward Looking Disclaimer This presentation contains certain statements that may be deemed "forward-looking statements." All statements in this document, other than statements of historical fact, that address events or developments that the Company expects to occur, are forward looking statements.
Slide 3: Company Overview
Company Overview Aurora Spine has developed a portfolio of solutions for the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies, making procedures easier and more effective for doctors and patients. • Headquartered in Carlsbad, CA • Emp
Slide 4: Mission & Philosophy
Mission & Philosophy Innovation targeted at each patient’s well-being Aurora began with a vision to develop high-quality, less invasive implants that prioritize the patient's health. Our philosophy is to make our implants match the patient's anatomy, not to make their anatomy fit our implants. Today
Slide 5: Recent Accomplishments
Recent Accomplishments • SiLO Franchise Gaining Sales Momentum: Sales of the • Record Revenues: Company reported SiLO-TFX SI joint implant increased 135% in 2024, due to record revenues for three consecutive investments in surgeon education, expansion of quarters and annually, with FY24 being instru
Slide 6: Back Pain Market And Patient Options
Back Pain Market And Patient Options Back Pain Market Treatment Intensity 30M+ in the U.S. suffer from lower back pain 13M+ go to the Non-Surgical Minimally Invasive Open Spine doctor each year for Management Surgery Surgery chronic back pain • Medications • Therapeutics • SI Joint Fusion • Cervical
Slide 7: Emerging Market – Pain Management
Emerging Market – Pain Management The global pain management devices market size is expected to reach USD $14.55 billion by 2026 Number of Pain registering a CAGR of 13.8%. Interventionalists vs. Aurora entered market in November 2020 Spine Surgeons • Introduced two key products for the pain market:
Slide 8: Growth Initiatives
Growth Initiatives Internal Sales & Marketing 1 CEO, 1 CCO & 1 VP of Sales 6 Regional Sales Directors 3 Territory Managers ~50 active distributors Aurora's Quality Management System is ISO 13485 MDSAP certified that allows the company to sell its products in Japan, Australia, Brazil, Canada and the
Slide 9: Key Value Creation Driver: Proprietary Products
KEY VALUE CREATION DRIVER: Proprietary Products Aurora Spine, Inc.
Slide 10: Proprietary Product Platforms
Proprietary Product Platforms Aurora Spine currently has several proprietary product platforms, created to add significant value to the company. SiLO / TFX Launched 2020 / 2023 Patented Technology FDA 510K Cleared SI Joint AERO Hydra Launching 2H 2025 Patent Pending zip FDA 510K Cleared Launched 201
Slide 11: Proprietary Product: zip Series
Proprietary Product: zip Series The zip is Aurora Spine’s minimally invasive interspinous fixation implant for spinal fusion (screwless procedure). It was developed as an alternative to pedicle screw fixation. • Over 10,000 procedures performed to date • Reduces OR time by 36%: 98 minutes vs. 153 mi
Slide 12: Proprietary Product: SiLO
Proprietary Product: SiLO SiLO Posterior Si Joint Fusion System • Addresses new market opportunity for Aurora Spine -- Joint Pain • Sacroiliac joint (Si Joint) fusion is a surgical procedure which fuses the iliac bone (pelvis) to the spine (sacrum) for stabilization. • The Global MIS Sacroiliac Join
Slide 13: Proprietary Product: SiLO TFX
Proprietary Product: SiLO TFX SiLO-TFXTM is Aurora Spine's MIS Transfixing Si Joint Fusion System. • A Crossover product: Ortho, Neuro, and Pain Physicians can all use this product. • Commercially Launched: Q2:23 • Fastest growing product for Aurora SiLO Revenue by Quarter $3 $2.3 $2.3 $2 $1.8 $1.7
Slide 14: Proprietary Product: DEXA Technology
Proprietary Product: DEXA Technology Having low bone density or osteoporosis affects 54 million Americans. DEXA can match the bone density of the patient and promote bone growth and provide better implantation. • Implant stiffness correlates to Bone Quality • Acts and looks like bone • DEXA tunes it
Slide 15: Proprietary Product: DEXA Technology & apollo
Proprietary Product: DEXA Technology & apollo • The apollo is part of the DEXA Technology family of products. • The system is comprised of cervical plates and bone screws constructed of titanium alloy. • A wide array of implant length options to match a variety of patient anatomies and to facilitate
Slide 16: Proprietary Product: HYDRA
Proprietary Product: HYDRA Pioneering Roughened Surface Technology in Spinal Screw Systems • Pioneering roughened surface technology • Complex spine, and minimally invasive spine procedures • Elevate stability, micromotion, and loosening Aurora Spine, Inc. 16
Slide 17: Proprietary Product: AERO Facet Fusion System
Proprietary Product: AERO Facet Fusion System • FDA 510(k) cleared March 2025 • Novel device designed to provide minimally invasive solution for patients suffering from facet joint-related pain or instability • Cleared for spinal levels C2 to S1 (inclusive) • Can be used in Lumbar and Cervical • Ini
Slide 18: Financials
FINANCIALS Aurora Spine, Inc.
Slide 19: Income Statement Highlights – Annual & YTD
Income Statement Highlights – Annual & YTD Revenue Gross Profit Margins Adjusted EBITDA $18 $17.6 70% $0 $0.3 60.5% $0 $16 60% 56.5% $14.8 52.5% $0 $14.3 $14 50% 45.8% ($0) 40.1% ($0) ($0.3) ($0.3) $12 $11.2 40% $ in USD $ in USD $10.5 31.8% ($1) ($0.5) $10 30% ($0.6) $8.6 ($1) $8 20% ($1) ($1) $6 1
Slide 20: Income Statement Highlights - Quarterly
Income Statement Highlights - Quarterly Revenue Gross Profit Margins Adjusted EBITDAC $5 65% $1 $4.8 $4.7 62.4% $0.4 61.9% $0 $4.4 60.5% $5 59.7% $0 60% $4.0 $4.1 57.8%58.0% $3.9 $3.9 56.9% 56.7% $0 $4 $0.1 $0.1 $0.1 $0.1 $3.6 $0 55% $ in USD $ in USD $4 51.7% $0 $3.0 ($0) ($0.0) 50% $3 ($0) ($0.2)
Slide 21: Balance Sheet Highlights
Balance Sheet Highlights $ in USD 3/31/2025 12/31/2024 12/31/2023 Cash and cash equivalents $488,693 $825,621 $766,829 Accounts receivable, net $4,098,086 $3,784,858 $3,968,439 Inventory $3,817,659 $3,613,557 $3,562,349 Total current assets $8,633,882 $8,500,120 $8,501,790 Property, plant and equipm
Slide 22: Capitalization Summary
Capitalization Summary Stock Details Key Shareholders Stock price: $0.25 25.2% - All Insiders (Board of Directors and 52-week range: $0.16-$0.34 Management) Shares outstanding: 77.4 million 16.1% - David Rosenkrantz, Chairman Market capitalization: $19.4 million 6.9% - Trent Northcutt, CEO 2.2% - Ot
Slide 23: Milestones And Objectives
Milestones And Objectives Proprietary product platforms to drive revenue growth and profitability • ZIPTM Interspinous Fixation Device – screwless procedure • SiLO-TFXTM – novel solution for SI Joint pain; growing rapidly in expanding market • DEXATM products: DEXA-C and DEXA-L; Apollo cervical plat
Slide 24: Appendix
APPENDIX Aurora Spine, Inc.
Slide 25: Management Team
Management Team Trent Northcutt Laszlo Garamszegi Dave Meyer Chad Clouse Chief Executive Officer Chief Technology Officer VP & Chief Legal Officer Chief Financial Officer • 20+ years experience in medical • 20+ years experience in medical • 25+ years of legal experience • 15+ years of corporate devi
Slide 26: Board Of Directors
Board Of Directors David Rosenkrantz Trent Northcutt Mike Seid Daryl Maclellan Tracy Graf Chairman CEO Board Member Board Member Board Member • 18+ years • 20+ years experience in • 17+ years of • President of Desante • President of Carfinco experience in medical device market investment, finance, F
Slide 27: Strong Patent Portfolio
Strong Patent Portfolio Title Ser. or Pat. No Filing Date Issue Date Continuity Data Status Dynamic and Non-Dynamic Interspinous Fusion Implant Granted 9,364,267 4-17-13 6-14-16 and Bone Growth Stimulation 7.5 Year MF Open 6-14-23 Aurora Spine’s Intellectual System Property Dynamic and Non-Dynamic I
Slide 28: Spine Surgery Market Overview
Spine Surgery Market Overview • Majority of spine surgery is targeted at relieving pain caused by disc injury or disease • Most surgeries involve damaged disc remediation or removal • Removal necessitates fusing together of the vertebrae above and below the damaged area • Vertebrae must be held in p